Cody Tranbarger and the View from the Goal

With ninety-four seconds left, Andrew Melvin tried a diving shot. Amherst was ahead of Bates, 10-8, in the 2015 conference semifinal. Cody Tranbarger stopped it. The score held. A game with dozens of shots, ground balls, passes, and decisions had narrowed to one attempt and the goalkeeper waiting for it.

Tranbarger finished with seventeen saves. Amherst advanced to the championship game and set a program record with its sixteenth win of the season. Those are the clean numbers. The less tidy part is the job itself: a goalkeeper can have an excellent afternoon and still spend much of it retrieving balls from the net. Success comes with a rather unceremonious view of failure.

More than a decade later, Tranbarger is founder and CEO of Mithril Medicine in Cambridge, Massachusetts. Between the goalmouth and the founder’s desk came biology and economics, investment banking, investing, a business-development role, and a return to university. His career has repeatedly changed the place from which he watches an organization work.

It would be convenient to declare that lacrosse taught him everything he needed to know about business. Convenient stories tend to save their authors more trouble than they save their subjects. His sporting record deserves attention on its own. So does the route that followed it.

The work behind the score

Tranbarger came to Amherst from Louisville, Kentucky, having attended Trinity High School. He played goalkeeper across four college seasons, appearing on the roster as a freshman in 2014 and a senior in 2017. By his senior year, the number beside his name was 3. The position beside it remained G.

His sophomore season gives the sports chapter its weight. In 2015, he recorded 315 saves in 21 appearances, averaging fifteen a game. His .621 save percentage led the conference’s overall season table. These are season totals, distinct from the statistics available when postseason honors were first announced.

The distinction matters. A season keeps moving after an award committee reaches its deadline. Tranbarger earned First Team All-NESCAC recognition that spring and an honorable mention All-America selection. His sixty saves in the conference tournament remain listed as the tournament record in the conference’s 2026 record book.

By April 2017, Amherst had another memorable afternoon against Tufts. Tranbarger made eighteen saves in a comeback win, twelve of them in the second half. Nine came in the third quarter alone. The action was concentrated precisely when his team needed to recover its footing.

Sports statistics can flatten a person into a row. They can also rescue an early chapter from being treated as ornamental. He was doing substantial work on a college field long before anyone introduced him with a company title. The goalkeeper’s task was immediate, visible, and shared with the players in front of him.

Biology, economics, and a change of seat

At Amherst, Tranbarger studied biology and economics, graduating magna cum laude. The pairing gave his academic life two different ways to ask how things work: one concerned with living systems, the other with choices, resources, and incentives. His later employment would bring those subjects into the same professional setting.

He began his career as an investment banking analyst at Goldman Sachs, evaluating and helping execute mergers, acquisitions, and financing transactions in the biotechnology sector. He later worked at Casdin Capital, where his responsibilities included leading an area of the firm’s research and investment effort. That was a move from advising on transactions toward evaluating investment opportunities.

At Prime Medicine, his work included business development. He was there during the company’s October 2022 initial public offering. A public listing puts a price on a business every trading day; it also changes the relationship between the company and the people watching it. Tranbarger had moved inside an operating organization, with colleagues and compensation of his own.

Seen together, these jobs are a sequence of changing seats. The banker helps arrange the transaction. The investor assesses the opportunity. The employee lives with the company’s daily decisions. Each has reasons to look at the same enterprise differently. Tranbarger’s later writing makes that difference particularly concrete.

A university with room for a company

In 2023, Tranbarger began Harvard’s joint MS/MBA program. The same year, he co-founded Revision Bio. The company was incubated at Harvard’s Pagliuca Life Lab, putting an entrepreneurial undertaking beside his academic work. A university, in this chapter, was both somewhere to study and somewhere a new organization could begin.

He completed the program in 2025, earning an MBA from Harvard Business School and an MS in biotechnology from Harvard’s Graduate School of Arts and Sciences. Harvard then named him a 2025-2026 Blavatnik Fellow. Its announcement identified two founding roles: co-founder of Revision Bio and founder and acting CEO of Mithril Medicine.

The fellowship offered a further year of support for new ventures, with guidance and a community of entrepreneurs. Tranbarger’s public response focused on continuing to build both companies with Harvard’s resources. The degree and the work were overlapping chapters rather than consecutive boxes on an application form.

Revision Bio was acquired in 2025. That milestone adds a completed transaction to his founding experience. Mithril Medicine has since become the company attached to his CEO title. By March 2026, he was entering another peer community, this time for first-time chief executives.

What the employee remembers

Some revealing material about a founder appears away from the company announcement. In August 2025, Tranbarger published an essay on employee stock option repricing. He disclosed that the options granted during his time at Prime Medicine had fallen deeply underwater and that he had never realized equity compensation from them.

He also described former coworkers as mentors and friends. The financial outcome had not erased the relationships. That combination gives the essay a personal stake without reducing it to a grievance. He had experienced the promise of equity compensation from the employee’s side, then examined the question as someone interested in governance.

“I am deeply grateful for my time at Prime.”Cody Tranbarger, August 2025

His discussion considers employee retention alongside shareholders’ interests. Repricing can renew an incentive, but its costs and benefits fall on different people. In a founder’s hands, the subject becomes a practical question about how an organization shares risk and reward. The spreadsheet eventually acquires names.

His writing has a less earthbound side, too. A May 2025 essay examined space-based manufacturing, opening with reusable rocket boosters and the prospect of Mars. Finance and orbital industry make an unusual pair of subjects for a founder’s reading list. They also give his public voice more range than a sequence of appointment announcements would suggest.

The title asked whether the idea was real. That question is a useful editorial choice: begin with curiosity, then ask what supports the claim. A rocket is an excellent way to get a reader’s attention. It is a less satisfactory substitute for doing the arithmetic.

Getting involved before getting a title

A separate strand of Tranbarger’s career began in 2019, while he was researching Harvard’s MBA program. He encountered Rich Horgan’s biography and kept thinking about the organization Horgan had started. His eventual approach was a LinkedIn message offering to help. It led to conversations, advisory work, corporate sponsors, and participation in a 2020 gala.

The sequence is refreshingly ordinary. A person reads something, thinks about it for a while, and sends a message. The work grows from there. There is no elaborate entrance ceremony; the first useful action is making contact. Tranbarger later described finding a team with which he wanted to partner.

His college years had included community involvement as well. In 2016, he spoke about helping bring the You’re With Us! program to Amherst and other schools across the Northeast. Coach Jon Thompson had facilitated the original connection to its founder, Michael Plansky. The relationship extended his participation in a team beyond the scoreboard.

These episodes show specific acts of engagement across different periods of his life. They also widen the cast of the story. Coaches, nonprofit founders, colleagues, and fellow entrepreneurs appear beside the institutions on his résumé. Organizations have names; the introductions that let someone join them usually have people behind them.

The next team

On March 24, 2026, the Termeer Institute named Tranbarger to its incoming class of fellows, identifying him as founder and CEO of Mithril Medicine. The cohort comprised seventeen first-time CEOs, with organizations across four American states and five countries. The program brings mentoring, executive coaching, professional development, and opportunities to learn with peers.

His biography also identifies him as an entrepreneur-in-residence at Atlas Venture. That places his current work within Cambridge’s company-building community while the fellowship adds another circle of people facing a similar change in responsibility. Becoming a chief executive creates decisions to make. It also creates reasons to seek advice.

Tranbarger’s route now includes a college sporting record, experience on both sides of investment decisions, two Harvard degrees, and a company acquisition. The next chapter is still being written at Mithril. The useful perspective comes from keeping the earlier chapters in view: the employee with underwater options, the student starting a company, the teammate making an introduction.

Back at Amherst, the semifinal clock reached zero after his late save. A founder gets fewer such tidy endings. A transaction closes; another organization needs building. A degree is awarded; another classroom appears. The goalkeeper who once looked out at ten players now works among a different set of teams, with a different sort of responsibility for what happens next.